Drugs Health Pharma

Israel’s Teva gets FDA nod for treating schizophrenia in adult patients

HQ Team October 10, 2026: Israel’s Teva Pharmaceutical Industries Ltd’s, Weltruza, a once-monthly injection for treatment of schizophrenia in adults, has been approved.

Read More